Engineering Prodrug Nanomedicine for Cancer Immunotherapy
Abstract Immunotherapy has shifted the clinical paradigm of cancer management. However, despite promising initial progress, immunotherapeutic approaches to cancer still suffer from relatively low response rates and the possibility of severe side effects, likely due to the low inherent immunogenicity...
Furkejuvvon:
| Váldodahkkit: | , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Wiley
2020-12-01
|
| Ráidu: | Advanced Science |
| Fáttát: | |
| Liŋkkat: | https://doi.org/10.1002/advs.202002365 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|